(secondQuint)Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-nave Wet Age-related Macular Degeneration Patients.

 Data will be collected from the medical files retro- and prospectively.

 If patients are still under treatment at study initiation and have not yet completed 24 months of treatment with intravitreal aflibercept in a treat-and-extend regimen, data of the remaining observation period will be collected prospectively.

.

 Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-nave Wet Age-related Macular Degeneration Patients@highlight

The purpose of this observational study lies in the analysis of a treat-and-extend injection scheme with intravitreal aflibercept (i.

e.

 injection into the eye), as applied in routine practice in previously untreated patients diagnosed with wet age-related macular degeneration.

